RGNX CIK: 1590877

REGENXBIO Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.52
FY22:
0.42
FY23:
0.33
FY24:
0.28
FY25:
0.28
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.60
FY22:
0.42
FY23:
0.24
FY24:
0.19
FY25:
0.17
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.11
FY22:
0.83
FY23:
0.57
FY24:
0.47
FY25:
0.45

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.13
FY22:
0.13
FY23:
0.13
FY24:
0.10
FY25:
0.12
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.22
FY22:
0.19
FY23:
0.13
FY24:
0.10
FY25:
0.23
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.76
FY22:
0.52
FY23:
0.31
FY24:
0.26
FY25:
0.10
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.11
FY22:
0.83
FY23:
0.57
FY24:
0.47
FY25:
0.45

All amounts in billions USD Data source:SEC EDGAR